Additional therapy with mistletoe extracts in breast cancer patients receiving chemotherapy. A prospective randomized open label pilot study

被引:0
|
作者
Troeger, Wilfried [1 ]
机构
[1] Clin Res Dr Troger, D-79110 Freiburg, Germany
关键词
Breast cancer; Chemotherapy; Mistletoe; Quality of life; Lymphocytes; Randomized clinical trial;
D O I
10.1016/j.phymed.2007.07.035
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
32
引用
收藏
页码:38 / 38
页数:1
相关论文
共 50 条
  • [1] Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial
    Troeger, Wilfried
    Zdrale, Zdravko
    Tisma, Nevena
    Matijasevic, Miodrag
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [2] A pilot study evaluating the benefits and feasibility of an exercise program for breast cancer patients receiving adjuvant chemotherapy.
    Petrella, T. M.
    Laredo, S.
    Oh, P.
    Marzolini, S.
    Warner, E.
    Dent, R.
    Verma, S.
    Eisen, A.
    Pritchard, K.
    Trudeau, M.
    Zhang, L.
    Bjarnason, G.
    CANCER RESEARCH, 2012, 72
  • [3] Quality of Life and Neutropenia in Patients with Early Stage Breast Cancer: A Randomized Pilot Study Comparing Additional Treatment with Mistletoe Extract to Chemotherapy Alone
    Trogerl, Wilfried
    Jezdic, Svetlana
    Zdrale, Zdravko
    Tisma, Nevena
    Hamre, Harald J.
    Matijasevic, Miodrag
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2009, 3 : 35 - 45
  • [4] Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical study
    Ivan Bačić
    Nikica Družijanić
    Robert Karlo
    Ivan Škifić
    Stjepan Jagić
    Journal of Experimental & Clinical Cancer Research, 29
  • [5] Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical study
    Bacic, Ivan
    Druzijanic, Nikica
    Karlo, Robert
    Skific, Ivan
    Jagic, Stjepan
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
  • [6] Survival of metastatic metaplastic breast cancer patients receiving chemotherapy.
    Kukunoor, Sparsha
    Lee, Anna
    Taiwo, Evelyn Oluwatoyin
    Schreiber, David
    Luhrs, Carol A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] A pilot study of tumor-derived exosomes as diagnostic and prognostic markers in breast cancer patients receiving neoadjuvant chemotherapy.
    Raab, R. E.
    Pawlowski, T. L.
    Spetzler, D.
    Klass, M. R.
    Kuslich, C. D.
    Bellin, L. S.
    Wong, J. H.
    Asch, A. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational study
    Araz, M.
    Karaagac, M.
    Korkmaz, L.
    Koral, L.
    Inci, F.
    Beypinar, I.
    Uysal, M.
    Artac, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 636 - 636
  • [9] Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study
    Hurria, Arti
    Rosen, Carol
    Hudis, Clifford
    Zuckerman, Enid
    Panageas, Katherine S.
    Lachs, Mark S.
    Witmer, Matthew
    van Gorp, Wilfred G.
    Fornier, Monica
    D'Andrea, Gabriella
    Moasser, Mark
    Dang, Chau
    Van Poznak, Catherine
    Hurria, Anju
    Holland, Jimmie
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (06) : 925 - 931
  • [10] Randomized pilot study of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy
    Basen-Engquist, Karen
    Murray, James L.
    Baum, George
    Gutierrez-Barrera, Angelica M.
    Arun, Banu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)